Article Details

Titan Pharmaceuticals (NASDAQ:TTNP) Earns Sell Rating from Analysts at StockNews.com

Retrieved on: 2022-12-14 08:58:57

Tags for this article:

Click the tags to see associated articles and topics

Titan Pharmaceuticals (NASDAQ:TTNP) Earns Sell Rating from Analysts at StockNews.com. View article details on hiswai:

Excerpt

Renaissance Technologies LLC now owns 240,710 shares of the specialty pharmaceutical company's stock valued at $135,000 after acquiring an additional ...

Article found on: reporter.am

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up